A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants

Clinical trial NCT06681181 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06681181
Sponsor: GlaxoSmithKline
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2024-11-18
Primary completion: 2026-04-23
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.